DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...

The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...

Yeztugo, a twice yearly injection, offers a promising advancement in HIV prevention, but high costs and insurance uncertainties may limit its accessibility.

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

The vast majority of positive tests have come from people in Bangor who have either been homeless, injection drug users, or ...

Experts welcome the news that PEPFAR funding remains intact, but few details about how and where services will be ...

The Jigawa State Agency for the Control of AIDS has announced plans to begin dispensing anti-retroviral drugs at primary ...